Dubovská D, Piotrovskij V K, Gajdos M, Krivosíková Z, Spustová V, Trnovec T
Institute of Preventive and Clinical Medicine, Bratislava, Slovakia.
Methods Find Exp Clin Pharmacol. 1995 Jan-Feb;17(1):67-77.
The pharmacokinetics of acetylsalicylic acid (ASA) and its metabolites salicylic acid (SA) and salicyluric acid (SUA) were studied in 12 healthy young volunteers after oral administration of low (30 and 100 mg) and moderate (400 mg) doses. Plasma and urine were assayed for the above drugs by high-performance liquid chromatographic method. Individual pharmacokinetic parameters were estimated by compartmental modeling (ASA and SA) and by model-independent methods (SUA). ASA parameter values estimated in this study were in agreement with those reported by other authors after administration of higher doses, which confirms the linearity of ASA pharmacokinetics in a broad dose range. On the contrary, both metabolic and renal elimination routes for SA were found to be saturable. The relative changes in SA renal clearance with the dose were more pronounced than those in metabolic clearance. Particularly, there was no statistically significant difference in SA metabolic clearance between 30 and 100 mg doses, indicating the linear kinetics in this dose range. Further increase in the dose resulted in significant decrease in SA metabolic clearance. At the same time, both SA excretion rate constant and fraction excreted significantly diminished across the entire dose range studied. The dependence of SUA renal clearance upon the dose was shown to be complex, reflecting possible saturability of its excretion.
在12名健康年轻志愿者口服低剂量(30毫克和100毫克)和中等剂量(400毫克)乙酰水杨酸(ASA)后,对其及其代谢产物水杨酸(SA)和水杨尿酸(SUA)的药代动力学进行了研究。采用高效液相色谱法测定血浆和尿液中的上述药物。通过房室模型(ASA和SA)和非模型依赖方法(SUA)估算个体药代动力学参数。本研究中估算的ASA参数值与其他作者在给予更高剂量后报告的值一致,这证实了ASA药代动力学在较宽剂量范围内的线性。相反,发现SA的代谢和肾脏消除途径均具有饱和性。SA肾脏清除率随剂量的相对变化比代谢清除率更为明显。特别是,30毫克和100毫克剂量之间的SA代谢清除率没有统计学上的显著差异,表明该剂量范围内的线性动力学。剂量进一步增加导致SA代谢清除率显著降低。同时,在整个研究剂量范围内,SA排泄速率常数和排泄分数均显著降低。SUA肾脏清除率对剂量的依赖性表现复杂,反映出其排泄可能具有饱和性。